Tobacco Documents Online

[Memo Regarding Industry Plans]

Abstract

Documents meeting discussion regarding direction and long-term plans of industry health research. States "CTR has helped in legal situations and as public statements - provision of witness." Discusses that "tobacco industry should and must continue to do research" and cites need for more "independent research." Debates whether CTR should have a "basic overall goal or give more money and let little projects proliferate." Suggests a move into more bronchial and cardiovascular research. Determines role of TI. Same as Bates #1000036636.

Fields

Quotes

"Nov. 15, 78 NY.C. 9:30 am Tim Finnegan, Charles Tucker, Janet Brown, Wally Hughes, Alex Spears, Ernie Pepple, Jim Bowling, RBS, TSO, Bill Shinn, Arnold Henson Pepples - asked to study industry health research - long term plans - This is an ad hoc group. Task to be completed by Spring '79. Proposals to be made to the CEO by general council Open to proposals - come back with general policy and research directions. Program carries vestiges of legal, PR and other problems. Shinn Litigation started in 1954 State of the Art of research CTR has helped in legal situations and as public statements - provision of witnesses. - Had a PR function - Introduction to witnesses. (Special project - defensive and direct. handled by CTR -- method of funding special investigations.) Over years loosing (sic.) its lustre. - special projects Harvard UCLA and Wash. U. - need responsible research which is totally independent - R.J.R - basic disease research is being supported. (Basic Res.) (Directed research - or problem oriented) (Tobacco oriented - less basic) J. Brown Function of SAB to oversee the research - 4th category - PR Opposition considers case closed Tob. Ind. should and must continue to do Research No Product Development! This is not priveledged [sic.] - no written notes to be sent to anyone. (only personal notes) Henson - approval for industry at this time much more restricted - new era of litigation Pepples - involve TI - to give them occasional witnesses - they have special needs. Shinn - problem with liason committee - differences in phylosophy [sic.] between the companies. - Policy committee will have to preceed [sic.] a Implementation Committee How does one handle Congressional hearings? - Pepples - Limitations when 2 or more companies collaborate. needs to offer some general principles for guide to companies for joint work. What should the mix be in various categories. What are the scientific directions want? Pepples - have another meeting including Senkus, Colby etc. Henson - come out with broad directions and then meet with the group. Hughes CTR program - what is their overall direction? - Get it more related to specific function. - Program based in history/not up to date no work on the effect. Therefore, focus program into basic overall objective or give more money and let little projects proliferates [sic.]? - Move more into bronchitic, cardiovascular etc. - What is the role of SAB - too diverse Pepples - SAB purports to measure relevance RBS - We do not know what is going on. ASpears - How does one come up with the objectives and portion out bucks. What are the needs? May need more than one organization to handle the various items which are needed. P. - Areas we should get into - RBS - Went through own list"

Type

Notes

Named Person

Tucker, Charles A. (RJR Director, 1973-89, TI Communications Comm. 1983)

Also on TI Comnmunications Committee, 1983

Finnegan, Timothy M. (Attorney, Jacob & Medinger)

Worked defending producers of smokeless tobacco (snuff).

Brown, Janet C. (CTR Director, Attorney, Chadbourne & Parke)

CTR Director 1/31/81

Hughes, Ivor Wallace

Spears, Alexander White, III (LOR President & CEO)

Associated with CTR, used as an expert in the Mississippi case.

Pepples, Ernest, J.D. (BW General Counsel and Sr. VP)

Bowling, James Chandler (PM; TI, Corporate Affairs Director & VP; Board of Dir.)

Vice President and Director of Sales at Philip Morris from 1967 to 1976. He was Senior Vice President of PM from 1977 to 1984 and on the Board of Directors from 1971 to 1984. Also worked for the Tobacco Institute. Attempted to improve the image of smoking in the face of negative health news.

Osdene, Thomas Stefan, Ph.D. (Director of Science and Technology, Philip Morris [1986])

Ph.D. in Organic Chemistry. Ten years of research when he started with PM in 1965. Worked in Chemical Research Division of PM 1965-66; Chemical and Biological Research Division 1966-69; Director of Research 1969-1984, also assumed independent position as Director of Research and Extramural Studies during these years; became Director of Science and Technology in 1984, reporting directly to Philip Morris USA Executive VP Mark Serrano. Involved with Center for Indoor Air Research (CIAR) 1988. Attended PM's Operation Downunder Conference in June, 1987. Retired 1993.

Shinn, William W. (TI Communications; Shook, Hardy, CTR Attorney)

TI Communications Committee and was also a lawyer for CTR. William W. Shinn worked for Shook, Hardy & Bacon.

Henson, Arnold (ATC General Counsel)

Defense

Colby

Senkus, M.

Named Organization

*Council for Tobacco Research-- U.S.A. Inc. CTR (Formerly Tobacco Industry Research Committee (TIRC))

Created and funded by the tobacco industry to award grants to study of the link between smoking and disease. Part of a four decade effort to cast doubt on the links between smoking and disease.

R.J. Reynolds Tobacco Co. (Cigarette manufacturer (Camel, Winston, Doral))

Cigarette manufacturer (Camel, Winston, Doral)

SAB

Tobacco Institute (Industry Trade Association)

The purpose of the Institute was to defeat legislation unfavorable to the industry, put a positive spin on the tobacco industry, bolster the industry's credibility with legislators and the public, and help maintain the controversy over "the primary issue" (the health issue).

Region

New York

Keyword

Special projects

SAB

Thesaurus Term

court

disease

industry front group

industry activity

industry sponsored research

industry strategy

litigation

adverse effects

industry response

cardiovascular disease

#18374 (bronchitis)

lawsuit